Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 22, 2018

DrugPatentWatch Database Preview

METOPROLOL TARTRATE Drug Profile

« Back to Dashboard

Which patents cover Metoprolol Tartrate, and when can generic versions of Metoprolol Tartrate launch?

Metoprolol Tartrate is a drug marketed by Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Luitpold, Mylan Asi, Sandoz Inc, Watson Labs, West-ward Pharms Int, Alembic Pharms Ltd, Apothecon, Aurobindo Pharma, Ipca Labs Ltd, Mylan, Purepac Pharm, Renata, Rubicon Res Pvt Ltd, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Yaopharma Co Ltd, and Sun Pharm Inds. and is included in thirty-four NDAs.

The generic ingredient in METOPROLOL TARTRATE is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.

Summary for METOPROLOL TARTRATE

US Patents:	0
Applicants:	24
NDAs:	34
Suppliers / Packagers:	55
Clinical Trials:	291
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	METOPROLOL TARTRATE at DailyMed

Drug patent expirations by year for METOPROLOL TARTRATE

Pharmacology for METOPROLOL TARTRATE

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

US Patents and Regulatory Information for METOPROLOL TARTRATE

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Inc	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	074644-002	Dec 10, 1996	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Purepac Pharm	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	074380-001	Jul 29, 1994		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Teva Pharms	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	074333-001	Jan 27, 1994		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Mylan	METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; metoprolol tartrate	TABLET;ORAL	076792-003	Aug 20, 2004	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys

Cantor Fitzgerald

Argus Health

Fuji

Merck

Johnson and Johnson

Queensland Health

Healthtrust

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.